Randomized Double Blind Placebo Controlled Trial of Barrett's Esophagus Chemoprevention With Metformin.

Trial Profile

Randomized Double Blind Placebo Controlled Trial of Barrett's Esophagus Chemoprevention With Metformin.

Completed
Phase of Trial: Phase II

Latest Information Update: 06 May 2014

At a glance

  • Drugs Metformin (Primary)
  • Indications Oesophageal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Apr 2013 Planned end date changed from 1 Jun 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.
    • 11 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 25 Mar 2012 New source identified and integrated (Mayo Clinic).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top